Almost one million children die annually from health impacts tied to growth failure, now a leading under-5 mortality risk.

Platelet-to-Lymphocyte Ratio (PLR): Elevated PLR is another key marker linked to more aggressive tumor characteristics, such ...

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

New campaign educates adults about vaccines that protect against flu, COVID-19 and RSV CHICAGO, Dec. 9, 2025 /PRNewswire/ -- Each winter, too many families across New England are impacted by ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with ...

Human Rights Day 2025 stresses that human rights are positive, essential, and attainable, urging nations to reconnect with freedoms that safeguard dignity and equality.

As the festive season approaches and Americans prepare for weeks of holiday parties, colder weather and gift-shopping marathons, new research from TENA, the global leader in incontinence care, reveals ...

GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in ...

As the world's first country to be prescribed for its health benefits, Sweden is now shining a light on one of its most awe-inducing wellness experiences. Aurora Borealis – the original arctic light ...

Such physical activity may help restore ease of movement and agility, which often decline as humans and animals get older, the study authors said. Led by NYU Langone Health researchers, the ...

(Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of Peptide-Related Impurities Identified in Generic Teriparatide Products." The study ...

The weekly dosing cohort achieved an estimated 87% reduction in annualized treated bleeding rate (ATBR) Results validate potential as the first prophylactic therapy to address the heavy physical and ...